Evaluation of real-time loop-mediated isothermal amplification (RealAmp) for rapid detection of Mycobacterium tuberculosis from sputum samples

Yiming Li, Lei Shi, Anqi Pan, Weiwei Cao, Xun Chen, Hecheng Meng, He Yan, Shin-ichi Miyoshi, Lei YeJournal of Microbiological Methods 2014 · DOI

TL;DR

This paper introduces and validates a rapid, portable, and cost-effective method called RealAmp for detecting Mycobacterium tuberculosis (MTB) in sputum samples. It demonstrates that RealAmp offers significantly higher sensitivity and speed compared to traditional smear microscopy and culture methods, making it a promising tool for widespread TB diagnosis, especially in resource-limited settings.

What Problem Does This Paper Address?

Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a major global health threat. Current diagnostic methods face significant challenges:

  • Culture-based methods: Considered the "gold standard," they are highly sensitive but notoriously slow, taking 3-6 weeks for results. This delay hinders timely treatment and disease control.
  • Smear microscopy: This is a rapid test but lacks sensitivity, meaning it can miss many TB cases.
  • PCR-based methods (like real-time PCR): While sensitive and relatively fast, these methods are expensive and require specialized laboratory infrastructure and skilled personnel, limiting their accessibility in many developing countries where TB is most prevalent.

The paper addresses the critical need for a diagnostic tool that is simultaneously rapid, sensitive, specific, and affordable, with the potential for use outside of traditional laboratory settings.

Methods

The core of this research is the development and evaluation of a real-time loop-mediated isothermal amplification (RealAmp) assay. Here's a breakdown of the key techniques:

  • Loop-Mediated Isothermal Amplification (LAMP): This is the foundational DNA amplification technique. Unlike PCR, LAMP operates at a constant temperature (60-65°C), eliminating the need for thermal cycling equipment. It uses a unique set of primers and a specialized polymerase (Bst DNA polymerase) to rapidly amplify target DNA through a strand displacement mechanism.
  • Real-time Fluorescence Detection (RealAmp): The "real-time" aspect comes from using a portable fluorescence detection system, the ESE Quant tube scanner. This device monitors the amplification process in real-time by detecting the fluorescence signal generated as the DNA amplifies. This allows for faster detection and quantification compared to traditional endpoint LAMP methods.
  • Primer Design: Specific primers targeting the IS6110 repetitive element of MTB were designed using the online Primer Explorer V4 software. This element is a well-established target for MTB detection.
  • Sample Processing: Sputum samples underwent a simplified DNA extraction process involving NaOH treatment, centrifugation, and boiling. This was designed to be quick and amenable to field use.
  • Comparison Assays: The RealAmp assay's performance was rigorously compared against:
  • Smear Microscopy: Standard Ziehl-Neelsen staining and light microscopy.
  • Conventional Culture: Egg-based Löwenstein-Jensen medium.
  • Commercial Real-time PCR: A validated kit for MTB detection.

Datasets

The study evaluated 1067 clinical sputum samples collected from May to September 2011. These samples were obtained from the Guangdong Provincial Tuberculosis Control Center in China. The study also used 15 characterized mycobacterial reference strains and several other bacterial species to assess the specificity of the RealAmp assay.

Key Insights and Ideas

  • The "Electricity-Free" Advantage: The ESE Quant tube scanner's ability to run on battery power is a game-changer for point-of-care diagnostics in remote or low-resource areas.
  • Speed and Sensitivity Synergy: RealAmp combines the isothermal simplicity of LAMP with real-time fluorescence detection, achieving a detection limit as low as 10² CFU/ml of MTB in just 20 minutes of reaction time. This is a significant improvement over traditional methods.
  • Unlocking "Invisible" Infections: RealAmp's higher sensitivity compared to smear and culture suggests it can detect MTB DNA from uncultured or even dead bacteria. This is crucial because it means RealAmp can identify cases missed by culture (due to bacterial viability issues) or smear (due to low bacterial load).
  • A Powerful Validation Tool: The study highlights RealAmp's potential to validate smear and culture-negative samples, helping to reduce false negatives and improve diagnostic accuracy.
  • Bridging the Gap: RealAmp offers a viable alternative to expensive PCR, providing a sensitive and specific diagnostic tool that is more accessible for widespread implementation.

Key Results

  • Detection Limit: The RealAmp assay demonstrated a low detection limit of 10² CFU/ml of MTB.
  • Reaction Time: The assay achieved results in approximately 20 minutes of reaction time, with amplification curves often appearing within 10 minutes for higher concentrations.
  • Clinical Sample Performance (vs. Culture):
    • Sensitivity: 96.70%
    • Specificity: 91.55%
    • Overall Coincidence Rate: 93.16%
  • Clinical Sample Performance (vs. Smear Microscopy):
    • Sensitivity: 95.29%
    • Specificity: 86.88%
    • Overall Coincidence Rate: 89.22%
  • Performance vs. Real-time PCR (on culture-negative samples):
    • Sensitivity: 98.25%
    • Specificity: 99.11%
    • Overall Coincidence Rate: 99.05%
  • Specificity: The assay showed high specificity, correctly identifying MTB strains while not amplifying DNA from other mycobacterial species or common respiratory pathogens.

Limitations and Future Work

  • Specificity in Discordant Cases: While RealAmp showed good sensitivity for samples with discordant culture and smear results, its specificity in these cases was lower (56.25%). This suggests that further investigation is needed to fully understand its utility in resolving such discrepancies.
  • Large-Scale Evaluation: The authors acknowledge that while their study involved a substantial number of samples (1067), large-scale evaluations are still needed to confirm the utility of RealAmp in resolving differences between culture and smear results.
  • Field Validation: Although the portability of the ESE Quant tube scanner is a major advantage, further studies are needed to validate the RealAmp assay's performance in actual field settings with varying environmental conditions and user expertise.
  • Cost-Effectiveness Analysis: While implied to be cost-effective, a formal economic analysis comparing RealAmp to existing methods would strengthen its adoption case.

Summary updated

BibTeX
@article{li2014evaluation,
  author = {Yiming Li and Lei Shi and Anqi Pan and Weiwei Cao and Xun Chen and Hecheng Meng and He Yan and Shin-ichi Miyoshi and Lei Ye},
  title = {{Evaluation of real-time loop-mediated isothermal amplification (RealAmp) for rapid detection of Mycobacterium tuberculosis from sputum samples}},
  journal = {Journal of Microbiological Methods},
  year = {2014},
  doi = {10.1016/j.mimet.2014.06.011},
}
Figure